European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Next PostHMOs offer protection from tooth decay as formula ingredient You Might Also Like HMOs in maternal and prenatal applications? Study uncovers presence in amniotic fluid April 8, 2019 What’s the latest in Prebiotic Research? – January 2023 Edition January 17, 2023 What’s the Latest in Prebiotic Research? – July 2023 Edition July 25, 2023